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Ultrasonically-Assisted Drug Delivery
in Rats Reduces Tumor Growth

#839
Introduction: Previously we have shown

Plurogel reduces tumor growth, but this is not solely because
there is more Dox in insonated tumors than in the tumors that
were not insonated. It is possible that US permeabilizes the
tumor tissue to allow greater drug uptake or more effective
toxicity.
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Results:4 Growth rates were calculated for insonated and control tumors, and

Cells

statistical analysis showed that insonated tumors significantly displayed slower
growth rate time constant (0.047/day vs. 0.040/day, p = 0.0047, Fig 3). Comparison
between tumors receiving 20 kHz and 500 kHz treatment showed no statistical
difference (p = 0.9277) in growth rate.
Results of the Dox analysis from the insonated and control tumors showed that in
the first 30 minutes (Fig 4), and perhaps the first 6 hrs there is slightly (~20%) more
Dox (p=0.055 of 0.064), but not beyond 6 hrs (p>0.9). It is noteworthy that the
insonated tumor had slower growth even though the amount of Dox was not that
much greater in the non-insonated tumor. This suggests that US is also affecting the
uptake and/or processing of the Dox by the tumor cells, and that the therapeutic
effect may not be attributed solely to a higher concentration of drug released by
insonation (Fig 5).
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release

Figure 1. Micelles release the encapsulated drug at the targeted
tissue upon application of ultrasound then quickly reform.

W/cm2

Figure 2. Rats with subcutaneous tumors grown on each leg. Ultrasound at 20 kHz, 1
(left and middle) and 500
kHz, 1 W/cm2 (right) was applied to one of the tumors while the other was the non-insonated contralateral control.

Methods: BDIX rats (24) were inoculated with the DHD/K12/TRb rat colonic cancer cell line in each lower leg. Half
received 20 kHz US, and the other 500 kHz US, both at the same mechanical index of 1.22 (see Fig 2). Plurogel® was
synthesized according to the method given by Pruitt3 and mixed with Dox. The mixture (2.67 mg Dox/kg) was injected into
anesthetized rats, and US was applied for 15 minutes on one tumor. Treatments were given weekly for six consecutive
weeks and both tumor dimensions were measured and recorded weekly.
After 6 weeks of treatment, rats were sacrificed at 1, 6, 12, 24, & 48 hours post US exposure. Both tumors were harvested
at necropsy and Dox was immediately extracted and its concentration in the tumor was measured by HPLC with
fluorescence detection.
Tumor volumes were analyzed using an exponential growth statistical model examining ultrasound treatment, frequency,
and days after initiation of treatment, and these were tested using F-tests.

REFERENCES: 1. Husseini,et al, J. Cont. Rel., 69, 43-52 (2000). 2. Nelson et al., Cancer Res. 62(24), 7280
(2002). 3. Pruitt et al, Macromolecules, 33, 9306 (2000). 4. Staples, BJ; MS Thesis, Brigham Young Univ, 2007.
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that nanosized drug carriers called Plurogels™
sequestered Doxorubicin (Dox) and partially
released this drug with application of
ultrasound (US) (Fig. 1)1. The application to
chemotherapy was successfully demonstrated
in a rat tumor model2. However previous
studies did not examine the distribution of Dox
in the insonated and control tissue. This recent
work investigated the effect of two US
frequencies and examined the Dox distribution
in the insonated and control tumors to
determine if US was depositing more Dox at
the insonated site.

Conclusions US combined with Dox-containing-
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Figure 4. Average Doxorubicin concentration from all of the rats in the
study. The black color () represents the Dox concentration in tumors
that received ultrasound. Red color () represents the concentration in
tumors that did not receive ultrasound. The orange ovals designate
the points for which the p-values were calculated.
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Figure 3. Tumor growth measurement data collected from two of the rats in the study. The left graph is
representative of the overall results of the study, and right graph shows an example of tumor regression.
The blue color () represent the measured volumes of the tumor that did not receive ultrasound. The pink
color () represent the measured volumes of the tumor that received ultrasound.
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Figure 5. Ultrasound is thought to permeabilize the
tissue, which allowed an increased uptake of the drug .
A higher concentration of drug is present in cells with
compromised membrane integrity. Plurogel =

